Short answer
For most people in the trials, Zepbound produced measurable weight loss within 2 to 3 months, but the full effect took much longer. In a SURMOUNT-1 analysis, 62% of people had lost at least 5% of their weight by week 8. Another found 82% had by week 12. The trial's main results were measured at 72 weeks, after up to 20 weeks of dose increases.
The first 8 to 12 weeks
Two post hoc analyses by Lilly-affiliated researchers looked at early weight loss in SURMOUNT-1. One, published in 2026, found that 62.1% of the tirzepatide-treated people it analyzed had lost at least 5% of body weight by week 8. At that point everyone had been on 5 mg for 4 weeks. The other, from 2025, included people who took at least 75% of their doses and found that 82% had lost at least 5% by week 12. These are subgroups, not the whole trial, and they cannot predict your own timeline.
Slower starters often caught up
The 2025 analysis called people with less than 5% loss at week 12 late responders. Of them, 70% had reached at least 5% by week 24, and 90% by week 72. Their mean time to reach 5% was 24.8 weeks. They still lost less on average than early responders: 11.0% against 22.5% at week 72. The 2026 analysis found the same pattern using week 8. Lilly funded both analyses.
Why the dose schedule matters
The label starts everyone at 2.5 mg once a week for 4 weeks, a dose for starting treatment, not a maintenance dose. Then it goes to 5 mg, with increases of 2.5 mg after at least 4 weeks on each dose. In SURMOUNT-1, people reached 5 mg at week 4, 10 mg at week 12 and 15 mg at week 20. The label says blood levels reach steady state after 4 weeks of weekly dosing. So someone headed for 15 mg spends at least 20 weeks getting there.
How results built over time
The label measured weight loss after 72 weeks, including at least 52 weeks on the maintenance dose. In SURMOUNT-4, adults on the highest dose they could tolerate, 10 mg or 15 mg, had lost an average of 20.9% after 36 weeks. Those who stayed on tirzepatide reached 25.3% by week 88. If you are unsure whether your progress is on track, ask your prescriber, who sets your dose.
Related questions
Should I lose weight on the 2.5 mg dose?
The label says the 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage. It gives no expected weight loss for that dose alone.
Does losing slowly at first mean Zepbound will not work?
Not necessarily. In a SURMOUNT-1 analysis, 90% of people who had lost less than 5% at week 12 had lost at least 5% by week 72, though they lost less on average.
When does weight loss level off?
In a separate SURMOUNT-1 analysis, the median time to a plateau ran from about 24 to 36 weeks, depending on starting weight.
Read next
Sources
- Eli Lilly: Zepbound prescribing information, sections 2, 12 and 14 (revised 08/2026)
- Diabetes, Obesity and Metabolism: Tirzepatide efficacy and tolerability according to early weight response, SURMOUNT-1 and -2, Kokkinos et al. (2026)
- Diabetes, Obesity and Metabolism: Weight reduction over time by early weight loss response, SURMOUNT-1, Ard et al. (2025)
- JAMA: Continued Treatment With Tirzepatide for Maintenance of Weight Reduction, SURMOUNT-4, Aronne et al. (2024)
- Clinical Obesity: Time to weight plateau with tirzepatide in SURMOUNT-1 and SURMOUNT-4, Horn et al. (2025)
Published 2026-10-07 · Last checked 2026-10-07
Educational content, not medical advice. Made for the United States.